Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific.

GILD (Common Stock)
Exchange	NASDAQ (US Dollar)
Price	$48.72
Change (%)	0.13 (0.27%)
Volume	8,181,866
Data as of 01/27/12 4:00 p.m. ET Minimum 20 minute delay Refresh quote

Recent News

More >>

Date	Title
01/26/12	Gilead Sciences to Release Fourth Quarter and Year End 2011 Financial Results on Thursday, February 2, 2012
01/24/12	Gilead Initiates Phase 2 Clinical Trial Evaluating GS-7340, A Low-Dose Novel Prodrug of Tenofovir for the Treatment of HIV
01/18/12	U.S. Food and Drug Administration Approves New Formulations of Viread® for Use by Children Living With HIV

Upcoming Events

More >>

There are currently no events scheduled.

Most Viewed Links

Updated 01/28/12

1.	SEC Filings
2.	Stock Quote
3.	Annual Reports
4.	Contact Information
5.	Fundamentals - Snapshot

* Data collected 01/04/12 - 01/11/12

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Gilead Sciences posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.